-
Garden Reach Sh.
3,034.00 1,180.10(%) -
Enviro Infra
251.85 392.00(%) -
Multi Comm. Exc.
8,808.85 8,357.25(%) -
Waaree Energies
3,097.15 3,740.75(%) -
Welspun Living
142.00 213.10(%) -
Vodafone Idea
7.19 19.15(%) -
M T N L
57.90 101.88(%) -
Bharat Electron
409.30 240.15(%) -
Cochin Shipyard
2,120.50 1,180.45(%) -
Sammaan Capital
146.45 179.35(%) -
Netwrk.18 Media
61.82 106.01(%) -
Mazagon Dock
3,224.45 1,917.95(%) -
Hind.Aeronautics
4,800.00 3,045.95(%) -
Hyundai Motor I
2,145.00 2,083.60(%) -
Tata Motors
678.80 1,179.05(%) -
BEML Ltd
4,422.00 2,346.35(%) -
Vishal Mega Mart
137.80 134.50(%) -
Dixon Technolog.
14,090.00 10,613.00(%) -
Data Pattern
2,805.00 1,350.50(%) -
Suzlon Energy
63.93 46.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Bafna Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 28611.0
- ISIN : INE878I01022
-
Today’s Low
75.00 -
Today’s High
78.00

-
Open
75.00 -
Perv Close
74.50 -
52W Low
69.00 -
52W High
96.00
Key Indicators
-
P/E(TTM)
28.92
-
Mar.Cap (₹Cr.)
181.99
-
Div & Yield %
0.00
-
Book Value(₹)
35.85
-
Debt-Equity Ratio
3.26
-
AGM Date
24-Jun-2025
-
EPS
2.66
-
P/E Ratio
28.92
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
181.99
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
23.66
-
BV (₹)
35.80
-
Sales( ₹ in Cr.)
145.86
-
NP (in Cr.)
6.30
-
NP Var(%)
-14.0
-
Div%
0.0
-
CPS (₹)
4.70
-
EPS (₹)
2.70
-
Traded Value (₹ in Lakhs)
181.99
-
52 Week High
96.00
-
52 Week Low
69.00
-
Price BSE
74.0
-
Price NSE
77.00
-
Market Capital( in Cr.)
181.99
-
P/C Ratio
16.30
-
P/E Ratio
28.90
-
Price Vs.BV
2.70
-
27-May-2025( 07:40)
Results - Announcements - Bafna... - Net profit of Bafna Pharmaceut...
-
21-May-2025( 10:24)
Corporate News - Bafna... - Bafna Pharmaceuticals will hol...
-
06-Feb-2025( 06:13)
Results - Announcements - Bafna... - Net profit of Bafna Pharmaceut...
-
28-Jan-2025( 05:34)
Corporate News - Bafna... - Bafna Pharmaceuticals will hol...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 152.47 | 115.35 | 85.14 | 71.22 | 42.47 | 43.63 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 152.47 | 115.35 | 85.14 | 71.22 | 42.47 | 43.63 |
Other Income | 3.52 | 3.27 | 1.70 | 0.75 | 0.26 | 0.39 |
Stock Adjustments | 4.85 | 2.91 | 1.77 | -2.95 | 3.24 | -0.81 |
Total Income | 160.84 | 121.53 | 88.61 | 69.02 | 45.97 | 43.21 |
EXPENDITURE : | ||||||
Raw Materials | 91.58 | 65.98 | 41.70 | 33.58 | 23.22 | 27.00 |
Power and Fuel Cost | 6.73 | 5.31 | 3.93 | 2.95 | 2.69 | 2.50 |
Employee Cost | 19.03 | 15.87 | 14.65 | 11.98 | 10.25 | 9.01 |
Other Manufacturing Expenses | 13.83 | 8.68 | 7.72 | 6.72 | 5.02 | 4.48 |
Selling and Administration Expenses | 13.98 | 5.39 | 6.92 | 2.67 | 3.18 | 3.13 |
Miscellaneous Expenses | 1.06 | 1.33 | 2.19 | 0.07 | 23.45 | 9.77 |
Employee Benefit Expenses | 19.03 | 15.87 | 14.65 | 11.98 | 10.25 | 9.01 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 146.20 | 102.55 | 77.11 | 57.97 | 67.80 | 55.89 |
Operating Profit | 14.63 | 18.99 | 11.50 | 11.04 | -21.84 | -12.68 |
Interest | 2.29 | 2.04 | 0.79 | 0.74 | 0.10 | 2.13 |
Gross Profit | 12.34 | 16.95 | 10.71 | 10.30 | -21.94 | -14.81 |
Depreciation | 5.00 | 5.33 | 5.49 | 4.48 | 3.27 | 3.42 |
Profit Before Tax | 7.34 | 11.62 | 5.22 | 5.82 | -25.21 | -18.23 |
Current Tax | 0.00 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 |
Reported Net Profit | 7.35 | 11.34 | 5.22 | 5.83 | -25.20 | -19.73 |
Extraordinary Items | 0.07 | 0.20 | -2.16 | 0.00 | -23.33 | 0.00 |
Adjusted Net Profit | 7.28 | 11.14 | 7.38 | 5.83 | -1.87 | -19.73 |
Adjustment below Net Profit | 0.04 | 0.15 | -0.02 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | -54.48 | -65.97 | -71.17 | -76.99 | -51.79 | -32.06 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | -47.10 | -54.48 | -65.97 | -71.17 | -76.99 | -51.79 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 3.11 | 4.79 | 2.21 | 2.46 | -106.54 | 0.00 |
Earnings Per Share(Adj)-Unit Curr | 3.11 | 4.79 | 2.21 | 2.46 | -106.54 | 0.00 |
Book Value | 34.17 | 31.05 | 26.19 | 24.00 | -18.64 | 8.79 |
Book Value(Adj)-Unit Curr | 34.17 | 31.05 | 26.19 | 24.00 | -18.64 | 8.79 |